The Amplatzer™ Septal Occluder is a percutaneous, transcatheter, atrial septal defect closure device intended for the occlusion of atrial septal defects (ASD) in secundum position or …

The AMPLATZER PFO Occluder fically designed to stop blood flow through all types of PFO (Figure 3). The device is placed in the PFO

Abbott’s Amplatzer Septal Occluder is a gold standard for atrial septal defects (ASD) treatment in percutaneous, transcatheter closure.

The addition of the Amplatzer Multifenestrated Septal Occluder - “Cribriform” to the Amplatzer family of occluders enables transcatheter closure for the majority of atrial septal defects.

Jul 21, 2023 · For 25 years, these devices have been helping treat congenital heart defects and reduce the risk of stroke, from our Amplatzer Amulet LAA Occluder to our smaller-than-a-pea …

The most commonly used device today is the Amplatzer septal occluder, developed in the 1990s by Dr. Kurt Amplatz. The Amplatzer septal occluder is a self-centering device with two circular …

Nov 25, 2014 · Closure of large atrial septal defects using the Amplatzer device is safe and effective in both adults and children. Superior and posterior rim deficiencies are associated …

The Amplatzer™ Talisman™ PFO Occluder is built off the device that created the category, sustained leadership over decades of use, and was the first device supported by positive trials …

Possible candidates for entry tear closure with Amplatzer plug placement are patients with small entry tears. It is essential to detect all entries in the lesions and be able to close all of them.

Over 25 years ago, we pioneered PFO closure with the Amplatzer™ PFO Occluder. Today, it is the most-studied — and most-trusted — device of its kind, with over 180,000 patients treated …